symbol,statement_type,period_end,line_item,value
HCG.NS,income,2025-03-31 00:00:00,Tax Effect Of Unusual Items,0.0
HCG.NS,income,2025-03-31 00:00:00,Tax Rate For Calcs,0.142732
HCG.NS,income,2025-03-31 00:00:00,Normalized EBITDA,4228600000.0
HCG.NS,income,2025-03-31 00:00:00,Total Unusual Items,0.0
HCG.NS,income,2025-03-31 00:00:00,Total Unusual Items Excluding Goodwill,0.0
HCG.NS,income,2025-03-31 00:00:00,Net Income From Continuing Operation Net Minority Interest,444100000.0
HCG.NS,income,2025-03-31 00:00:00,Reconciled Depreciation,2113400000.0
HCG.NS,income,2025-03-31 00:00:00,Reconciled Cost Of Revenue,10622700000.0
HCG.NS,income,2025-03-31 00:00:00,EBITDA,4228600000.0
HCG.NS,income,2025-03-31 00:00:00,EBIT,2115200000.0
HCG.NS,income,2025-03-31 00:00:00,Net Interest Income,-1545600000.0
HCG.NS,income,2025-03-31 00:00:00,Interest Expense,1545600000.0
HCG.NS,income,2025-03-31 00:00:00,Interest Income,
HCG.NS,income,2025-03-31 00:00:00,Normalized Income,444100000.0
HCG.NS,income,2025-03-31 00:00:00,Net Income From Continuing And Discontinued Operation,444100000.0
HCG.NS,income,2025-03-31 00:00:00,Total Expenses,20422000000.0
HCG.NS,income,2025-03-31 00:00:00,Rent Expense Supplemental,
HCG.NS,income,2025-03-31 00:00:00,Diluted Average Shares,141433121.0
HCG.NS,income,2025-03-31 00:00:00,Basic Average Shares,139216301.0
HCG.NS,income,2025-03-31 00:00:00,Diluted EPS,3.14
HCG.NS,income,2025-03-31 00:00:00,Basic EPS,3.19
HCG.NS,income,2025-03-31 00:00:00,Diluted NI Availto Com Stockholders,444100000.0
HCG.NS,income,2025-03-31 00:00:00,Net Income Common Stockholders,444100000.0
HCG.NS,income,2025-03-31 00:00:00,Otherunder Preferred Stock Dividend,0.0
HCG.NS,income,2025-03-31 00:00:00,Net Income,444100000.0
HCG.NS,income,2025-03-31 00:00:00,Minority Interests,-44200000.0
HCG.NS,income,2025-03-31 00:00:00,Net Income Including Noncontrolling Interests,488300000.0
HCG.NS,income,2025-03-31 00:00:00,Net Income Continuous Operations,488300000.0
HCG.NS,income,2025-03-31 00:00:00,Tax Provision,81300000.0
HCG.NS,income,2025-03-31 00:00:00,Pretax Income,569600000.0
HCG.NS,income,2025-03-31 00:00:00,Other Non Operating Income Expenses,348100000.0
HCG.NS,income,2025-03-31 00:00:00,Special Income Charges,0.0
HCG.NS,income,2025-03-31 00:00:00,Other Special Charges,
HCG.NS,income,2025-03-31 00:00:00,Write Off,
HCG.NS,income,2025-03-31 00:00:00,Restructuring And Mergern Acquisition,
HCG.NS,income,2025-03-31 00:00:00,Net Non Operating Interest Income Expense,-1545600000.0
HCG.NS,income,2025-03-31 00:00:00,Total Other Finance Cost,
HCG.NS,income,2025-03-31 00:00:00,Interest Expense Non Operating,1545600000.0
HCG.NS,income,2025-03-31 00:00:00,Interest Income Non Operating,
HCG.NS,income,2025-03-31 00:00:00,Operating Income,1759400000.0
HCG.NS,income,2025-03-31 00:00:00,Operating Expense,9799300000.0
HCG.NS,income,2025-03-31 00:00:00,Other Operating Expenses,4198200000.0
HCG.NS,income,2025-03-31 00:00:00,Depreciation And Amortization In Income Statement,2113400000.0
HCG.NS,income,2025-03-31 00:00:00,Amortization,
HCG.NS,income,2025-03-31 00:00:00,Depreciation Income Statement,2113400000.0
HCG.NS,income,2025-03-31 00:00:00,Selling General And Administration,
HCG.NS,income,2025-03-31 00:00:00,Selling And Marketing Expense,
HCG.NS,income,2025-03-31 00:00:00,General And Administrative Expense,
HCG.NS,income,2025-03-31 00:00:00,Rent And Landing Fees,
HCG.NS,income,2025-03-31 00:00:00,Gross Profit,11558700000.0
HCG.NS,income,2025-03-31 00:00:00,Cost Of Revenue,10622700000.0
HCG.NS,income,2025-03-31 00:00:00,Total Revenue,22181400000.0
HCG.NS,income,2025-03-31 00:00:00,Operating Revenue,22181400000.0
HCG.NS,income,2024-03-31 00:00:00,Tax Effect Of Unusual Items,15203780.271707
HCG.NS,income,2024-03-31 00:00:00,Tax Rate For Calcs,0.389841
HCG.NS,income,2024-03-31 00:00:00,Normalized EBITDA,3469200000.0
HCG.NS,income,2024-03-31 00:00:00,Total Unusual Items,39000000.0
HCG.NS,income,2024-03-31 00:00:00,Total Unusual Items Excluding Goodwill,39000000.0
HCG.NS,income,2024-03-31 00:00:00,Net Income From Continuing Operation Net Minority Interest,481400000.0
HCG.NS,income,2024-03-31 00:00:00,Reconciled Depreciation,1743600000.0
HCG.NS,income,2024-03-31 00:00:00,Reconciled Cost Of Revenue,8889900000.0
HCG.NS,income,2024-03-31 00:00:00,EBITDA,3508200000.0
HCG.NS,income,2024-03-31 00:00:00,EBIT,1764600000.0
HCG.NS,income,2024-03-31 00:00:00,Net Interest Income,-1087400000.0
HCG.NS,income,2024-03-31 00:00:00,Interest Expense,1087400000.0
HCG.NS,income,2024-03-31 00:00:00,Interest Income,126970000.0
HCG.NS,income,2024-03-31 00:00:00,Normalized Income,457603780.271707
HCG.NS,income,2024-03-31 00:00:00,Net Income From Continuing And Discontinued Operation,481400000.0
HCG.NS,income,2024-03-31 00:00:00,Total Expenses,17526400000.0
HCG.NS,income,2024-03-31 00:00:00,Rent Expense Supplemental,218400000.0
HCG.NS,income,2024-03-31 00:00:00,Diluted Average Shares,140349854.0
HCG.NS,income,2024-03-31 00:00:00,Basic Average Shares,139132948.0
HCG.NS,income,2024-03-31 00:00:00,Diluted EPS,3.43
HCG.NS,income,2024-03-31 00:00:00,Basic EPS,3.46
HCG.NS,income,2024-03-31 00:00:00,Diluted NI Availto Com Stockholders,481400000.0
HCG.NS,income,2024-03-31 00:00:00,Net Income Common Stockholders,481400000.0
HCG.NS,income,2024-03-31 00:00:00,Otherunder Preferred Stock Dividend,0.0
HCG.NS,income,2024-03-31 00:00:00,Net Income,481400000.0
HCG.NS,income,2024-03-31 00:00:00,Minority Interests,68200000.0
HCG.NS,income,2024-03-31 00:00:00,Net Income Including Noncontrolling Interests,413200000.0
HCG.NS,income,2024-03-31 00:00:00,Net Income Continuous Operations,413200000.0
HCG.NS,income,2024-03-31 00:00:00,Tax Provision,264000000.0
HCG.NS,income,2024-03-31 00:00:00,Pretax Income,677200000.0
HCG.NS,income,2024-03-31 00:00:00,Other Non Operating Income Expenses,169400000.0
HCG.NS,income,2024-03-31 00:00:00,Special Income Charges,39000000.0
HCG.NS,income,2024-03-31 00:00:00,Other Special Charges,-38880000.0
HCG.NS,income,2024-03-31 00:00:00,Write Off,4320000.0
HCG.NS,income,2024-03-31 00:00:00,Restructuring And Mergern Acquisition,
HCG.NS,income,2024-03-31 00:00:00,Net Non Operating Interest Income Expense,-1087400000.0
HCG.NS,income,2024-03-31 00:00:00,Total Other Finance Cost,76610000.0
HCG.NS,income,2024-03-31 00:00:00,Interest Expense Non Operating,1087400000.0
HCG.NS,income,2024-03-31 00:00:00,Interest Income Non Operating,126970000.0
HCG.NS,income,2024-03-31 00:00:00,Operating Income,1552300000.0
HCG.NS,income,2024-03-31 00:00:00,Operating Expense,8636500000.0
HCG.NS,income,2024-03-31 00:00:00,Other Operating Expenses,3853000000.0
HCG.NS,income,2024-03-31 00:00:00,Depreciation And Amortization In Income Statement,1743600000.0
HCG.NS,income,2024-03-31 00:00:00,Amortization,77250000.0
HCG.NS,income,2024-03-31 00:00:00,Depreciation Income Statement,1743600000.0
HCG.NS,income,2024-03-31 00:00:00,Selling General And Administration,1079950000.0
HCG.NS,income,2024-03-31 00:00:00,Selling And Marketing Expense,401240000.0
HCG.NS,income,2024-03-31 00:00:00,General And Administrative Expense,678710000.0
HCG.NS,income,2024-03-31 00:00:00,Rent And Landing Fees,218400000.0
HCG.NS,income,2024-03-31 00:00:00,Gross Profit,10188800000.0
HCG.NS,income,2024-03-31 00:00:00,Cost Of Revenue,8889900000.0
HCG.NS,income,2024-03-31 00:00:00,Total Revenue,19078700000.0
HCG.NS,income,2024-03-31 00:00:00,Operating Revenue,19078700000.0
HCG.NS,income,2023-03-31 00:00:00,Tax Effect Of Unusual Items,-97836000.0
HCG.NS,income,2023-03-31 00:00:00,Tax Rate For Calcs,0.3
HCG.NS,income,2023-03-31 00:00:00,Normalized EBITDA,3324380000.0
HCG.NS,income,2023-03-31 00:00:00,Total Unusual Items,-326120000.0
HCG.NS,income,2023-03-31 00:00:00,Total Unusual Items Excluding Goodwill,-326120000.0
HCG.NS,income,2023-03-31 00:00:00,Net Income From Continuing Operation Net Minority Interest,293490000.0
HCG.NS,income,2023-03-31 00:00:00,Reconciled Depreciation,1634730000.0
HCG.NS,income,2023-03-31 00:00:00,Reconciled Cost Of Revenue,7997550000.0
HCG.NS,income,2023-03-31 00:00:00,EBITDA,2998260000.0
HCG.NS,income,2023-03-31 00:00:00,EBIT,1363530000.0
HCG.NS,income,2023-03-31 00:00:00,Net Interest Income,-866680000.0
HCG.NS,income,2023-03-31 00:00:00,Interest Expense,914730000.0
HCG.NS,income,2023-03-31 00:00:00,Interest Income,118100000.0
HCG.NS,income,2023-03-31 00:00:00,Normalized Income,521774000.0
HCG.NS,income,2023-03-31 00:00:00,Net Income From Continuing And Discontinued Operation,293490000.0
HCG.NS,income,2023-03-31 00:00:00,Total Expenses,15107190000.0
HCG.NS,income,2023-03-31 00:00:00,Rent Expense Supplemental,111550000.0
HCG.NS,income,2023-03-31 00:00:00,Diluted Average Shares,139073790.0
HCG.NS,income,2023-03-31 00:00:00,Basic Average Shares,139073790.0
HCG.NS,income,2023-03-31 00:00:00,Diluted EPS,2.1
HCG.NS,income,2023-03-31 00:00:00,Basic EPS,2.11
HCG.NS,income,2023-03-31 00:00:00,Diluted NI Availto Com Stockholders,293490000.0
HCG.NS,income,2023-03-31 00:00:00,Net Income Common Stockholders,293490000.0
HCG.NS,income,2023-03-31 00:00:00,Otherunder Preferred Stock Dividend,0.0
HCG.NS,income,2023-03-31 00:00:00,Net Income,293490000.0
HCG.NS,income,2023-03-31 00:00:00,Minority Interests,117190000.0
HCG.NS,income,2023-03-31 00:00:00,Net Income Including Noncontrolling Interests,176300000.0
HCG.NS,income,2023-03-31 00:00:00,Net Income Continuous Operations,176300000.0
HCG.NS,income,2023-03-31 00:00:00,Tax Provision,272500000.0
HCG.NS,income,2023-03-31 00:00:00,Pretax Income,448800000.0
HCG.NS,income,2023-03-31 00:00:00,Other Non Operating Income Expenses,6060000.0
HCG.NS,income,2023-03-31 00:00:00,Special Income Charges,-326470000.0
HCG.NS,income,2023-03-31 00:00:00,Other Special Charges,9350000.0
HCG.NS,income,2023-03-31 00:00:00,Write Off,317120000.0
HCG.NS,income,2023-03-31 00:00:00,Restructuring And Mergern Acquisition,0.0
HCG.NS,income,2023-03-31 00:00:00,Net Non Operating Interest Income Expense,-866680000.0
HCG.NS,income,2023-03-31 00:00:00,Total Other Finance Cost,70050000.0
HCG.NS,income,2023-03-31 00:00:00,Interest Expense Non Operating,914730000.0
HCG.NS,income,2023-03-31 00:00:00,Interest Income Non Operating,118100000.0
HCG.NS,income,2023-03-31 00:00:00,Operating Income,1653280000.0
HCG.NS,income,2023-03-31 00:00:00,Operating Expense,7109640000.0
HCG.NS,income,2023-03-31 00:00:00,Other Operating Expenses,1785330000.0
HCG.NS,income,2023-03-31 00:00:00,Depreciation And Amortization In Income Statement,1634730000.0
HCG.NS,income,2023-03-31 00:00:00,Amortization,114450000.0
HCG.NS,income,2023-03-31 00:00:00,Depreciation Income Statement,1520280000.0
HCG.NS,income,2023-03-31 00:00:00,Selling General And Administration,1010790000.0
HCG.NS,income,2023-03-31 00:00:00,Selling And Marketing Expense,336500000.0
HCG.NS,income,2023-03-31 00:00:00,General And Administrative Expense,674290000.0
HCG.NS,income,2023-03-31 00:00:00,Rent And Landing Fees,111550000.0
HCG.NS,income,2023-03-31 00:00:00,Gross Profit,8762920000.0
HCG.NS,income,2023-03-31 00:00:00,Cost Of Revenue,7997550000.0
HCG.NS,income,2023-03-31 00:00:00,Total Revenue,16760470000.0
HCG.NS,income,2023-03-31 00:00:00,Operating Revenue,16760470000.0
HCG.NS,income,2022-03-31 00:00:00,Tax Effect Of Unusual Items,282273000.0
HCG.NS,income,2022-03-31 00:00:00,Tax Rate For Calcs,0.3
HCG.NS,income,2022-03-31 00:00:00,Normalized EBITDA,2358520000.0
HCG.NS,income,2022-03-31 00:00:00,Total Unusual Items,940910000.0
HCG.NS,income,2022-03-31 00:00:00,Total Unusual Items Excluding Goodwill,940910000.0
HCG.NS,income,2022-03-31 00:00:00,Net Income From Continuing Operation Net Minority Interest,537330000.0
HCG.NS,income,2022-03-31 00:00:00,Reconciled Depreciation,1582840000.0
HCG.NS,income,2022-03-31 00:00:00,Reconciled Cost Of Revenue,6820730000.0
HCG.NS,income,2022-03-31 00:00:00,EBITDA,3299430000.0
HCG.NS,income,2022-03-31 00:00:00,EBIT,1716590000.0
HCG.NS,income,2022-03-31 00:00:00,Net Interest Income,-828050000.0
HCG.NS,income,2022-03-31 00:00:00,Interest Expense,838870000.0
HCG.NS,income,2022-03-31 00:00:00,Interest Income,115610000.0
HCG.NS,income,2022-03-31 00:00:00,Normalized Income,-121307000.0
HCG.NS,income,2022-03-31 00:00:00,Net Income From Continuing And Discontinued Operation,537330000.0
HCG.NS,income,2022-03-31 00:00:00,Total Expenses,13056930000.0
HCG.NS,income,2022-03-31 00:00:00,Rent Expense Supplemental,92800000.0
HCG.NS,income,2022-03-31 00:00:00,Diluted Average Shares,135182425.0
HCG.NS,income,2022-03-31 00:00:00,Basic Average Shares,129707612.0
HCG.NS,income,2022-03-31 00:00:00,Diluted EPS,3.97
HCG.NS,income,2022-03-31 00:00:00,Basic EPS,4.14
HCG.NS,income,2022-03-31 00:00:00,Diluted NI Availto Com Stockholders,537330000.0
HCG.NS,income,2022-03-31 00:00:00,Net Income Common Stockholders,537330000.0
HCG.NS,income,2022-03-31 00:00:00,Otherunder Preferred Stock Dividend,0.0
HCG.NS,income,2022-03-31 00:00:00,Net Income,537330000.0
HCG.NS,income,2022-03-31 00:00:00,Minority Interests,148080000.0
HCG.NS,income,2022-03-31 00:00:00,Net Income Including Noncontrolling Interests,389250000.0
HCG.NS,income,2022-03-31 00:00:00,Net Income Continuous Operations,389250000.0
HCG.NS,income,2022-03-31 00:00:00,Tax Provision,488470000.0
HCG.NS,income,2022-03-31 00:00:00,Pretax Income,877720000.0
HCG.NS,income,2022-03-31 00:00:00,Other Non Operating Income Expenses,4950000.0
HCG.NS,income,2022-03-31 00:00:00,Special Income Charges,939670000.0
HCG.NS,income,2022-03-31 00:00:00,Other Special Charges,-1337890000.0
HCG.NS,income,2022-03-31 00:00:00,Write Off,472450000.0
HCG.NS,income,2022-03-31 00:00:00,Restructuring And Mergern Acquisition,-74230000.0
HCG.NS,income,2022-03-31 00:00:00,Net Non Operating Interest Income Expense,-828050000.0
HCG.NS,income,2022-03-31 00:00:00,Total Other Finance Cost,104790000.0
HCG.NS,income,2022-03-31 00:00:00,Interest Expense Non Operating,838870000.0
HCG.NS,income,2022-03-31 00:00:00,Interest Income Non Operating,115610000.0
HCG.NS,income,2022-03-31 00:00:00,Operating Income,774450000.0
HCG.NS,income,2022-03-31 00:00:00,Operating Expense,6236200000.0
HCG.NS,income,2022-03-31 00:00:00,Other Operating Expenses,1765620000.0
HCG.NS,income,2022-03-31 00:00:00,Depreciation And Amortization In Income Statement,1582840000.0
HCG.NS,income,2022-03-31 00:00:00,Amortization,119500000.0
HCG.NS,income,2022-03-31 00:00:00,Depreciation Income Statement,1463340000.0
HCG.NS,income,2022-03-31 00:00:00,Selling General And Administration,604900000.0
HCG.NS,income,2022-03-31 00:00:00,Selling And Marketing Expense,181060000.0
HCG.NS,income,2022-03-31 00:00:00,General And Administrative Expense,423840000.0
HCG.NS,income,2022-03-31 00:00:00,Rent And Landing Fees,92800000.0
HCG.NS,income,2022-03-31 00:00:00,Gross Profit,7010650000.0
HCG.NS,income,2022-03-31 00:00:00,Cost Of Revenue,6820730000.0
HCG.NS,income,2022-03-31 00:00:00,Total Revenue,13831380000.0
HCG.NS,income,2022-03-31 00:00:00,Operating Revenue,13831380000.0
HCG.NS,income,2021-03-31 00:00:00,Tax Effect Of Unusual Items,
HCG.NS,income,2021-03-31 00:00:00,Tax Rate For Calcs,
HCG.NS,income,2021-03-31 00:00:00,Normalized EBITDA,
HCG.NS,income,2021-03-31 00:00:00,Total Unusual Items,
HCG.NS,income,2021-03-31 00:00:00,Total Unusual Items Excluding Goodwill,
HCG.NS,income,2021-03-31 00:00:00,Net Income From Continuing Operation Net Minority Interest,
HCG.NS,income,2021-03-31 00:00:00,Reconciled Depreciation,
HCG.NS,income,2021-03-31 00:00:00,Reconciled Cost Of Revenue,
HCG.NS,income,2021-03-31 00:00:00,EBITDA,
HCG.NS,income,2021-03-31 00:00:00,EBIT,
HCG.NS,income,2021-03-31 00:00:00,Net Interest Income,
HCG.NS,income,2021-03-31 00:00:00,Interest Expense,
HCG.NS,income,2021-03-31 00:00:00,Interest Income,156110000.0
HCG.NS,income,2021-03-31 00:00:00,Normalized Income,
HCG.NS,income,2021-03-31 00:00:00,Net Income From Continuing And Discontinued Operation,
HCG.NS,income,2021-03-31 00:00:00,Total Expenses,
HCG.NS,income,2021-03-31 00:00:00,Rent Expense Supplemental,53840000.0
HCG.NS,income,2021-03-31 00:00:00,Diluted Average Shares,
HCG.NS,income,2021-03-31 00:00:00,Basic Average Shares,
HCG.NS,income,2021-03-31 00:00:00,Diluted EPS,
HCG.NS,income,2021-03-31 00:00:00,Basic EPS,
HCG.NS,income,2021-03-31 00:00:00,Diluted NI Availto Com Stockholders,
HCG.NS,income,2021-03-31 00:00:00,Net Income Common Stockholders,
HCG.NS,income,2021-03-31 00:00:00,Otherunder Preferred Stock Dividend,
HCG.NS,income,2021-03-31 00:00:00,Net Income,
HCG.NS,income,2021-03-31 00:00:00,Minority Interests,
HCG.NS,income,2021-03-31 00:00:00,Net Income Including Noncontrolling Interests,
HCG.NS,income,2021-03-31 00:00:00,Net Income Continuous Operations,
HCG.NS,income,2021-03-31 00:00:00,Tax Provision,
HCG.NS,income,2021-03-31 00:00:00,Pretax Income,
HCG.NS,income,2021-03-31 00:00:00,Other Non Operating Income Expenses,
HCG.NS,income,2021-03-31 00:00:00,Special Income Charges,
HCG.NS,income,2021-03-31 00:00:00,Other Special Charges,510000.0
HCG.NS,income,2021-03-31 00:00:00,Write Off,804460000.0
HCG.NS,income,2021-03-31 00:00:00,Restructuring And Mergern Acquisition,0.0
HCG.NS,income,2021-03-31 00:00:00,Net Non Operating Interest Income Expense,
HCG.NS,income,2021-03-31 00:00:00,Total Other Finance Cost,62320000.0
HCG.NS,income,2021-03-31 00:00:00,Interest Expense Non Operating,
HCG.NS,income,2021-03-31 00:00:00,Interest Income Non Operating,156110000.0
HCG.NS,income,2021-03-31 00:00:00,Operating Income,
HCG.NS,income,2021-03-31 00:00:00,Operating Expense,
HCG.NS,income,2021-03-31 00:00:00,Other Operating Expenses,
HCG.NS,income,2021-03-31 00:00:00,Depreciation And Amortization In Income Statement,
HCG.NS,income,2021-03-31 00:00:00,Amortization,120280000.0
HCG.NS,income,2021-03-31 00:00:00,Depreciation Income Statement,
HCG.NS,income,2021-03-31 00:00:00,Selling General And Administration,411990000.0
HCG.NS,income,2021-03-31 00:00:00,Selling And Marketing Expense,135740000.0
HCG.NS,income,2021-03-31 00:00:00,General And Administrative Expense,276250000.0
HCG.NS,income,2021-03-31 00:00:00,Rent And Landing Fees,53840000.0
HCG.NS,income,2021-03-31 00:00:00,Gross Profit,
HCG.NS,income,2021-03-31 00:00:00,Cost Of Revenue,
HCG.NS,income,2021-03-31 00:00:00,Total Revenue,
HCG.NS,income,2021-03-31 00:00:00,Operating Revenue,
